Table 2. Distribution of patients according to the clinical characteristics of leprosy reactions.
Clinical characteristics | Studied groups | Statistical test | |||
---|---|---|---|---|---|
HIV and Leprosy | Leprosy | ||||
N | % | N | % | ||
Leprosy reaction | |||||
Yes | 15 | 37.5 | 60 | 56.1 | Relative risk = 0.47 |
No | 25 | 62.5 | 47 | 43.9 | p = 0.0026 |
Total | 40 | 100 | 107 | 100 | IC95% = 0.28–0.79 |
Type of reaction | |||||
Type 1 | 13 | 86.7 | 34 | 56.6 | G test |
Type 2 | 2 | 13.3 | 22 | 36.7 | p = 0.0750 |
Type 1 and 2 | 0 | 0.0 | 4 | 6.7 | |
Total | 15 | 100 | 60 | 100 | |
Neuritis | |||||
Present | 7 | 17.5 | 27 | 25.2 | Chi-squared |
Absent | 33 | 82.5 | 80 | 74.8 | p = 0.4414 |
Total | 40 | 100 | 107 | 100 | |
Prednisone dose | |||||
None | 26 | 65 | 71 | 66.3 | G test |
40 to 50 mg | 4 | 10.0 | 5 | 4.7 | p = 0.6672 |
≥ 50 mg | 10 | 25 | 31 | 29.0 | |
Total | 40 | 100 | 107 | 100 |
Source: Research Protocol, 2012.